MétaCan
Menu
← Back to cohort
Record W4390195234 · doi:10.1002/alz.076986

Molecular biomarkers quantified using the Single Molecule Array in Brazilian patients with mild Alzheimer’s disease and mild cognitive impairment

2023· article· en· W4390195234 on OpenAlexaboutno aff
Thamires Naela Cardoso Magalhães, Camila Vieira de Ligo Teixeira, Adriel S. Moraes, Ana Flavia M K C Cassani, Helena Passarelli Giroud Joaquim, Leda Leme Talib, Orestes Vicente Forlenza, Márcio Luiz Figueredo Balthazar, Charlotte E. Teunissen

Bibliographic record

VenueAlzheimer s & Dementia · 2023
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsnot available
Fundersnot available
KeywordsCerebrospinal fluidGlial fibrillary acidic proteinPathophysiologyBiomarkerMedicineInternal medicineCognitive impairmentMontreal Cognitive AssessmentPathologyGastroenterologyDiseaseOncologyImmunohistochemistryBiology

Abstract

fetched live from OpenAlex

Abstract Background The clinically diagnosed late‐onset Alzheimer’s disease (AD) cases has the most heterogeneous pathology. The development of more sensitive biomarkers is essential to perform an early diagnosis, especially in the prodromal phase, mild cognitive impairment (MCI). Biomarkers such as glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) have emerged as potential markers of the pathophysiological process of AD. The objective of this study was to evaluate the concentrations of GFAP and NfL in blood serum and CSF of patients with MCI and mild AD in a Brazilian sample, never quantified using the Single Molecule Array technology (Simoa). Method We used samples (blood serum and cerebrospinal fluid (CSF)) from 91 participants to perform molecular analyzes. These participants were recruited in the outpatient service of the UNICAMP Clinic Hospital. All participants underwent blood collection and only the patients, lumbar puncture, to analyze GFAP and NfL levels. All patients had pathophysiological evidence of AD (low Aβ1‐42 concentrations < 540pg/mL) and was considered Tau alteration: p‐Tau > 36.7 pg/mL and t‐Tau > 76.7 pg/mL. Result Statistical analyzes were performed using SPSS software (version 25). We performed a multivariate analysis of covariance (MANCOVA) to compare the biomarkers levels between the groups. To compare CSF levels (Aβ42, t‐Tau, p‐Tau, GFAP and NfL) we used T‐test analyses and to correlate GFAP and NfL with CSF proteins we use partial correlations. We did not find statistical differences between the groups regarding GFAP and NfL levels, but we did find differences between Aβ1‐42 protein between MCI and mild AD (p = 0.003). We also found moderate correlations between t‐Tau, GFAP and NfL CSF levels (r = .625, p = 0.0; r = .508, p = 0.005, respectively), and p‐Tau with GFAP CSF levels (r = .373, p = 0.046). Conclusion GFAP and NfL reflect neuro‐axonal damage and recent studies have demonstrated its effectiveness in tracking disease progression (5). Although we did not find differences between individuals in relation to GFAP and NfL markers, we were able to observe correlations between these markers at the CSF level and the proteins classically related to the pathological process of the disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.028

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.310
Teacher spread0.269 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicAlzheimer's disease research and treatments→French-language works237,207→